Suzhou Fushilai Pharmaceutical (301258.SZ) obtained the registration certificate for L-cysteine tablets.
Fuji Lei (301258.SZ) announcement, the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for thioparcacid tablets. Indication of thioparcacid tablets: Used for sensory abnormalities caused by diabetic peripheral neuropathy.
Suzhou Fushilai Pharmaceutical (301258.SZ) announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Lipoic Acid Tablets. The indications for Lipoic Acid Tablets are: used for sensory abnormalities caused by peripheral neuropathy in diabetes.
Related Articles

Synopsys, Inc. (SNPS.US) "AI gear shifting" strategy taking effect: Joining forces with NVIDIA Corporation to boost performance, guidance exceeds expectations.

Adobe (ADBE.US) Q4 performance and 2026 fiscal year guidance both exceeded expectations, but market anxiety about AI disruption remains difficult to dispel.

Zhii Mining (02546) will conduct a global public offering of 122 million H shares from December 11th to December 16th, introducing cornerstone investors such as Spaco.
Synopsys, Inc. (SNPS.US) "AI gear shifting" strategy taking effect: Joining forces with NVIDIA Corporation to boost performance, guidance exceeds expectations.

Adobe (ADBE.US) Q4 performance and 2026 fiscal year guidance both exceeded expectations, but market anxiety about AI disruption remains difficult to dispel.

Zhii Mining (02546) will conduct a global public offering of 122 million H shares from December 11th to December 16th, introducing cornerstone investors such as Spaco.

RECOMMEND

McDonald’s to Evaluate Franchisee Pricing for Customer Value Under Revised Standards
10/12/2025

Baidu’s AI Ace Kunlunxin Prepares For Hong Kong IPO, Domestic Computing Power Faces Crucial Test
08/12/2025

Institutions Say Short-Term Volatility Does Not Alter Upward Trend Of Hong Kong Stocks, Hang Seng Index Still Expected To Challenge 30,000 Points Next Year
08/12/2025


